ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,723Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 19

$1.74M Total Retail Price of All Prescriptions

Rank: 2 out of 19

767 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 767 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

15% of this provider’s 767 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 29,480 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 36.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
WARFARIN SODIUM 2,216 2,045 1 1
LEVOTHYROXINE SODIUM 1,169 1,091 2 3
NAMENDA 1,161 1,127 3 4
FUROSEMIDE 1,123 1,028 4 2
LISINOPRIL 1,074 1,032 5 7
METOPROLOL TARTRATE 892 773 6 5
DIVALPROEX SODIUM 825 697 7 16
ESCITALOPRAM OXALATE 799 784 8 12
SIMVASTATIN 682 551 9 15
SERTRALINE HCL 626 500 10 18
MIRTAZAPINE 622 597 11 17
AMLODIPINE BESYLATE 610 538 12 6
OMEPRAZOLE 610 575 12 14
POTASSIUM CHLORIDE 607 553 14 11
DONEPEZIL HCL 588 584 15 9
GABAPENTIN 480 397 16 10
RANITIDINE HCL 399 349 17 21
LANTUS 388 360 18 29
METFORMIN HCL 378 316 19 20
CITALOPRAM HBR 364 353 20 13
HYDROCODONE-ACETAMINOPHEN 324 290 S3 21 8
ALBUTEROL SULFATE 317 314 22 45
EXELON 315 306 23 26
CEPHALEXIN 312 268 24 41
POLYETHYLENE GLYCOL 3350 311 275 25 34
PREDNISONE 295 288 26 28
QUETIAPINE FUMARATE 291 281 27 30
IPRATROPIUM-ALBUTEROL 276 261 28 31
CARVEDILOL 262 233 29 22
KLOR-CON M20 250 249 30 79
LEXAPRO 243 239 31 48
TRAMADOL HCL 234 225 32 23
RISPERIDONE 214 169 33 27
TAMSULOSIN HCL 213 175 34 39
NOVOLIN R 208 196 35 73
CLOPIDOGREL 205 184 36 38
KLOR-CON M10 196 194 37 92
CARBIDOPA-LEVODOPA 190 190 38 61
BENAZEPRIL HCL 179 178 39 82
GLIPIZIDE 168 168 40 42
PAROXETINE HCL 165 143 41 96
DIGOXIN 163 163 42 47
ISOSORBIDE MONONITRATE ER 161 160 43 40
CYMBALTA 156 145 44 37
FENTANYL 156 152 S2 44 70
LEVETIRACETAM 152 103 46 35
FLUTICASONE PROPIONATE 152 106 46 77
ADVAIR DISKUS 147 141 48 68
DOXYCYCLINE HYCLATE 147 127 48 75
PANTOPRAZOLE SODIUM 147 146 48 57
OLANZAPINE 145 136 51 49
SEROQUEL 144 144 52 64
CIPROFLOXACIN HCL 142 134 53 55
PLAVIX 139 127 54 67
DILTIAZEM HCL 137 127 55 74
BACLOFEN 136 73 56 71
METOPROLOL SUCCINATE 133 98 57 50
ALLOPURINOL 133 124 57 59
LATANOPROST 132 124 59 86
CEFDINIR 131 123 60 85
DIOVAN 125 113 61 51
PHENYTOIN SODIUM EXTENDED 124 114 62 76
SPIRIVA 122 111 63 98
NITROGLYCERIN PATCH 120 108 64 106
TRAZODONE HCL 119 104 65 24
NYSTATIN 113 101 66 56
CLONIDINE HCL 110 78 67 84
LEVOFLOXACIN 110 105 67 52
ATORVASTATIN CALCIUM 110 88 67 33
DIVALPROEX SODIUM ER 109 87 70 81
NOVOLOG 106 88 71 60
PROMETHAZINE HCL 105 85 R 72 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 92 73 62
METOCLOPRAMIDE HCL 101 58 74 63
RIVASTIGMINE 100 100 75 121
SPIRONOLACTONE 94 91 76 93
TRAVATAN Z 91 89 77 91
FAMOTIDINE 90 52 78 36
ZOLPIDEM TARTRATE 90 84 78 45
HYDROCHLOROTHIAZIDE 87 74 80 32
NYSTOP 87 85 80 137
CARBAMAZEPINE 85 53 82 116
ROPINIROLE HCL 84 82 83 88
LABETALOL HCL 84 65 83 158
ATENOLOL 82 82 85 54
BUMETANIDE 81 81 86 182
LEVEMIR 81 61 86 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 64 88 135
HUMULIN R 76 75 89 124
PRAVASTATIN SODIUM 73 62 90 25
LOSARTAN POTASSIUM 72 65 91 58
FLUCONAZOLE 70 60 92 108
NEXIUM 69 62 93 43
HUMALOG 69 67 93 95
GLIPIZIDE ER 67 66 95 195
TRIAMCINOLONE ACETONIDE 67 55 95 110
TOPIRAMATE 66 40 97 198
SINGULAIR 65 53 98 138
ENALAPRIL MALEATE 64 43 99 111
CEFTRIAXONE 63 59 100 87
METOLAZONE 62 60 101 101
DILANTIN 62 47 101 157
LYRICA 60 52 103 113
ALENDRONATE SODIUM 60 60 103 104
PROPRANOLOL HCL 60 48 103 167
SYMBICORT 58 56 106 151
AMIODARONE HCL 58 58 106 161
VENLAFAXINE HCL ER 57 40 108 94
HYDRALAZINE HCL 56 39 109 66
NUEDEXTA 56 38 109 167
ENOXAPARIN SODIUM 56 54 109 162
RISPERDAL CONSTA 55 50 112 219
BRIMONIDINE TARTRATE 54 54 113 140
ISOSORBIDE DINITRATE 54 46 113 141
DILTIAZEM 24HR ER 53 52 115 105
DILTIAZEM 24HR CD 53 53 115 107
OXCARBAZEPINE 51 40 117 149
LUMIGAN 51 51 117 229
SANTYL 50 48 119 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.